Problem statement: Answer the multiple choice question.
Query: Which drug exhibits a -14.121% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a.) NN/C(=N\S(=O)(=O)c1ccccc1)Nc1cccc(Cl)c1
b.) CC1(C)Cc2c(sc3c2C2=NCCN2C=N3)CO1.Cl
c.) O=C(O)COc1ccc(-c2nccc(-c3ccccn3)n2)cc1
Answer: a. NN/C(=N\S(=O)(=O)c1ccccc1)Nc1cccc(Cl)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
NN/C(=N\S(=O)(=O)c1ccccc1)Nc1cccc(Cl)c1
NN/C(=N\S(=O)(=O)c1ccccc1)Nc1cccc(Cl)c1
1-amino-2-(benzenesulfonyl)-3-(3-chlorophenyl)guanidine